|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.065 SEK | +8.67% |
|
+12.34% | -76.64% |
| 03-28 | Elicera Therapeutics AB Announces Director Changes | CI |
| 03-06 | Elicera Enters Agreement with Prominent US Cancer Center to Evaluate the Use of ITANK in T-Cell Receptor Therapies | CI |
Elicera Therapeutics AB (publ) announced Annual General Meeting will be held on May 16, 2024, Jan Zetterberg has declined re-election.
| 1st Jan change | Capi. | |
|---|---|---|
| -76.64% | 3.21M | |
| +32.09% | 694B | |
| +29.39% | 593B | |
| -1.34% | 371B | |
| +20.34% | 331B | |
| +7.39% | 290B | |
| +14.25% | 239B | |
| -3.03% | 209B | |
| +10.02% | 209B | |
| +8.49% | 169B |
ELICERA THERAPEUTICS AB 